We've found
15,419
archived clinical trials in
Pulmonary
We've found
15,419
archived clinical trials in
Pulmonary
Non-invasive Intervention for Apnea of Prematurity
Updated: 3/17/2016
Neuromodulation of Limb Proprioceptive Afferents Using a Vibratory Device to Decrease Apnea, Intermittent Hypoxia and Bradycardia of Prematurity.
Status: Enrolling
Updated: 3/17/2016
Non-invasive Intervention for Apnea of Prematurity
Updated: 3/17/2016
Neuromodulation of Limb Proprioceptive Afferents Using a Vibratory Device to Decrease Apnea, Intermittent Hypoxia and Bradycardia of Prematurity.
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Updated: 3/17/2016
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Updated: 3/22/2016
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea
Updated: 3/23/2016
Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea
Status: Enrolling
Updated: 3/23/2016
Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea
Updated: 3/23/2016
Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease
Updated: 3/23/2016
Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease
Status: Enrolling
Updated: 3/23/2016
Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease
Updated: 3/23/2016
Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates
Updated: 3/24/2016
The Use of Lung Ultrasound to Diagnose RDS vs. TTN in Neonates Greater Than or Equal to 28 Weeks Gestation
Status: Enrolling
Updated: 3/24/2016
Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates
Updated: 3/24/2016
The Use of Lung Ultrasound to Diagnose RDS vs. TTN in Neonates Greater Than or Equal to 28 Weeks Gestation
Status: Enrolling
Updated: 3/24/2016
Click here to add this to my saved trials
Assessing Respiratory Variability During Mechanical Ventilation in Acute Lung Injury (ALI)
Updated: 3/28/2016
Assessing Respiratory Variability During Mechanical Ventilation in Acute Lung Injury
Status: Enrolling
Updated: 3/28/2016
Assessing Respiratory Variability During Mechanical Ventilation in Acute Lung Injury (ALI)
Updated: 3/28/2016
Assessing Respiratory Variability During Mechanical Ventilation in Acute Lung Injury
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP)
Updated: 3/28/2016
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials